0120-0534

S0120-05342018000300160

10.14349/rlp.2018.v50.n3.3

España

Spain

España

Spain

Portugal

España

00 12 2018

50 3 160 169

2008 20 1 1

27-36

2006 81 3 3

313-22

2014 5 5

2014

American Psychiatric Association

2013

2011 36 8 8

829-34

2008 66 3 3

243-52

1994 50 1 1

7-15

2000 10 3 3

295-307

1999 19 13 13

5473-81

2001 39 4 4

376-89

2017 95 1-2 1-2

136-47

2016 21 5 5

1052-9

2017 25 4 4

322

1998 13 7 7

585-95

2004 161 7 7

1181-9

2005 27 8 8

1022-32

2011 33 1 1

61-8

1994

1998 13 8 8

663-82

2016 28 4 4

2011 35 3 3

377-406

1999 7 5 5

377-415

2006 175 11 11

1385

2009 11 4 4

243-6

2015 47 3 3

213221

2017 13

19-24

2014 35 2 2

133-40

2010 33 2 2

339-55

2008 40

327-43

2012 37 3 3

306-12

2001 13 4 4

439-55

2007

2005 162 8 8

1403-13

2013 132 1 1

2937

Bol Del Estado 298 2 2

43088-99

2011 23 1 1

45-52

2016 23 1 1

42-50

2011 23 2 2

2000 41 1 1

49-100

2001 130 4 4

621

2011 23 4 4

277-87

2008

National Institute of Drug Abuse 2009

2013 210 3 3

871-9

Observatorio Español de la Droga y las Toxicomanías

2016

2008 34 1 1

109-21

2011 52 3 3

163-72

2010

2014

2013

2015 2 3 3

326-38

2011 53 53

483-93

2008 30 2 2

146-53

2011

2012 107 11 11

1957-62

2003 160 6 6

1078-85

2004

United Nations Office on Drugs and Crime Informe Mundial sobre las Drogas. (UNODC) 2016

2016 165

9-14

2014 21 4 4

288-96

2016 48 3 3

147-58

2016 68 68

270-81

2003

421-34

2004 38 7 7

601-6

2006 46 1-2 1-2

2007 190 4 4

517-30

2009

179-208

2017 78 48-55 48-55

VEdeTTE Study Group 2016 51 3 3

295-309

2016 374 4 4

363-71

2014 134

194-200

2007 26 1 1

33-9